Farther Finance Advisors, LLC Ptc Therapeutics, Inc. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 351 shares of PTCT stock, worth $26,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
351
Previous 223
57.4%
Holding current value
$26,430
Previous $13.7 Million
94.81%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PTCT
# of Institutions
338Shares Held
84.8MCall Options Held
810KPut Options Held
207K-
Vanguard Group Inc Valley Forge, PA8.8MShares$663 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$585 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$583 Million6.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.92MShares$370 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X03.77MShares$284 Million0.11% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $5.39B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...